评论：丹克斯等人于2020年发表的《医疗保健专业人员在慢性阻塞性肺疾病新药评估中首选的疗效终点和最小临床重要差异》；第10卷：第1519页。 - Suppr

Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in 2020; 10: 1519.

作者信息

Alma Harma, de Jong Corina, Kocks Janwillem, van der Molen Thys

机构信息

Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

出版信息

Front Pharmacol. 2020 Jun 2;11:827. doi: 10.3389/fphar.2020.00827. eCollection 2020.

DOI:10.3389/fphar.2020.00827

PMID:32581793

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7280745/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ebc/7280745/752de92f4742/fphar-11-00827-g001.jpg

相似文献

Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in 2020; 10: 1519.

Front Pharmacol. 2020 Jun 2;11:827. doi: 10.3389/fphar.2020.00827. eCollection 2020.

Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease.

Front Pharmacol. 2020 Feb 6;10:1519. doi: 10.3389/fphar.2019.01519. eCollection 2019.

Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.

Health Qual Life Outcomes. 2018 Jun 26;16(1):130. doi: 10.1186/s12955-018-0950-7.

Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.

J Clin Epidemiol. 2019 Dec;116:49-61. doi: 10.1016/j.jclinepi.2019.07.015. Epub 2019 Jul 27.

Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference.

NPJ Prim Care Respir Med. 2016 Sep 1;26:16041. doi: 10.1038/npjpcrm.2016.41.

Clinically relevant differences in COPD health status: systematic review and triangulation.

Eur Respir J. 2018 Sep 6;52(3). doi: 10.1183/13993003.00412-2018. Print 2018 Sep.

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.

NPJ Prim Care Respir Med. 2017 Feb 2;27(1):7. doi: 10.1038/s41533-016-0002-x.

Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.

Chronic Obstr Pulm Dis. 2017 Mar 2;4(2):124-131. doi: 10.15326/jcopdf.4.2.2017.0130.

The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?

Int J Chron Obstruct Pulmon Dis. 2016 Jul 7;11:1543-51. doi: 10.2147/COPD.S104947. eCollection 2016.

Validation and clinical interpretation of the St George's respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD.

Health Qual Life Outcomes. 2020 May 13;18(1):138. doi: 10.1186/s12955-020-01393-1.

本文引用的文献

Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.

J Clin Epidemiol. 2019 Dec;116:49-61. doi: 10.1016/j.jclinepi.2019.07.015. Epub 2019 Jul 27.

Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice.

BMJ Open. 2019 Jun 28;9(6):e025776. doi: 10.1136/bmjopen-2018-025776.

Clinically relevant differences in COPD health status: systematic review and triangulation.

Eur Respir J. 2018 Sep 6;52(3). doi: 10.1183/13993003.00412-2018. Print 2018 Sep.

Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.

Health Qual Life Outcomes. 2018 Jun 26;16(1):130. doi: 10.1186/s12955-018-0950-7.

Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference.

NPJ Prim Care Respir Med. 2016 Sep 1;26:16041. doi: 10.1038/npjpcrm.2016.41.

The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD.

Eur Respir J. 2015 Dec;46(6):1598-604. doi: 10.1183/13993003.00535-2015. Epub 2015 Oct 22.

A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 7;10:725-38. doi: 10.2147/COPD.S77368. eCollection 2015.

Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Int J Chron Obstruct Pulmon Dis. 2012;7:697-709. doi: 10.2147/COPD.S32675. Epub 2012 Oct 16.

Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level.

Health Qual Life Outcomes. 2010 Nov 16;8:135. doi: 10.1186/1477-7525-8-135.

Understanding the minimum clinically important difference: a review of concepts and methods.

Spine J. 2007 Sep-Oct;7(5):541-6. doi: 10.1016/j.spinee.2007.01.008. Epub 2007 Apr 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in 2020; 10: 1519.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献